About the Authors

Ilya Kovalenko

Affiliations Drug Discovery, Therapeutic Research Groups / Onc II, Bayer Pharma AG, Berlin, Germany, Department of Bioanalytics, Institute of Biotechnology, Technische Universität Berlin, Berlin, Germany

Andrea Glasauer

Affiliation Drug Discovery, Therapeutic Research Groups / Onc II, Bayer Pharma AG, Berlin, Germany

Laura Schöckel

Affiliation Drug Discovery, Therapeutic Research Groups / Onc II, Bayer Pharma AG, Berlin, Germany

Daniel R. P. Sauter

Current address: Sophion-Biolin Scientific, Copenhagen, Denmark

Affiliation Section for Cell Biology and Physiology, Department of Biology, University of Copenhagen, Copenhagen, Denmark

Alexander Ehrmann

Affiliation Drug Discovery, Lead Discovery / Cell Biology, Bayer Pharma AG, Berlin, Germany

Florian Sohler

Affiliation Drug Discovery, Therapeutic Research Groups / Bioinformatics, Bayer Pharma AG, Leverkusen, Germany

Andrea Hägebarth

Affiliation Drug Discovery, Therapeutic Research Groups / Onc II, Bayer Pharma AG, Berlin, Germany

Ivana Novak

Affiliation Section for Cell Biology and Physiology, Department of Biology, University of Copenhagen, Copenhagen, Denmark

Sven Christian

sven.christian@bayer.com

Affiliation Drug Discovery, Therapeutic Research Groups / Onc II, Bayer Pharma AG, Berlin, Germany

Competing Interests

I. Kovalenko, L. Schoeckel, A. Glasauer, A. Ehrmann, F. Sohler, A. Haegebarth and S. Christian are employees of Bayer Pharmaceuticals. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: SC IN. Performed the experiments: IK LS AG DRPS. Analyzed the data: IK LS AG DRPS AE FS AH IN SC. Wrote the paper: IK LS AG DRPS AE FS AH IN SC. Analysed expression databases: FS.